Session Details
Sunday, 8:00AM - 9:15AM PST
Session: SYM33 Location: WEST 3018
Current Approaches to Myopia Control
Symposium
In Person, Live Broadcast, On Demand
Topic: Optics, Refraction, Contact Lenses
Chair(s):
Joann J Kang, MD
Christina R Prescott, MD, PHD
Vishal Jhanji, MD, FRCOphth
8:00 | Myopia Therapy with Orthokeratology Tania M Cunha Schaefer, MD |
|
8:08 | Q&A | |
8:10 | Update on Atropine Studies for Myopia Control Michael X Repka, MD, MBA |
|
8:18 | Q&A | |
8:20 | Use of Multifocal Contact Lenses for Myopia Control Amy K Hutchinson MD |
|
8:28 | Q&A | |
8:30 | Genetics and Mechanisms of Myopia David Anthony Mackey MD |
|
8:38 | Q&A | |
8:40 | International Update on the Myopia Pandemic Jason Yam, FRCS(ED), MBBS |
|
8:48 | Q&A | |
8:50 | Whitney G Sampson Lecture: Violet Light Hypothesis for the Control of Myopia Progression Kazuo Tsubota MD |
|
9:10 | Q&A Joann J Kang, MD |
Description
Cosponsored by the Eye and Contact Lens Association (ECLA)
Myopia is a global public health epidemic, especially in Asian and industrialized countries. In addition to the significant social and economic burden, the pathologic complications of myopia are one of the leading causes of visual impairment worldwide. It is thus crucial to slow the onset and progression of myopia. This symposium will focus on recent innovations in myopia control techniques and management options and will present an update on the latest research interventions in development.
Disclosures
Joann J Kang, MD: Sanofi: C; Sight Sciences, Inc.: C; Christina R Prescott, MD, PHD: Johnson & Johnson Vision: C; Vishal Jhanji, MD, FRCOphth: None; Tania M Cunha Schaefer, MD: None; Michael X Repka, MD, MBA: Abbvie: C; Alcon Laboratories, Inc.: C; Luminopia: C; Amy K Hutchinson MD: None; David Anthony Mackey MD: editas: C; Health Advances: C; Lakshimi: C; Novartis, Alcon Pharmaceuticals: C; Jason Yam, FRCS(ED), MBBS: None; Kazuo Tsubota MD: Tsubota Laboratory, Inc.: E;